A cost-effectiveness evaluation of imatinib versus interferon-alpha plus low-dose Ara-C for first-line treatment of patients with newly diagnosed chronic myeloid leukemia in the chronic phase.

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Reed, SD; Anstrom, KJ; Foster, JA; Glendening, AG; Schulman, KA

Published Date

  • November 16, 2003

Published In

Volume / Issue

  • 102 / 11

Start / End Page

  • 252A - 252A

Published By

Pages

  • 1

International Standard Serial Number (ISSN)

  • 0006-4971

Conference Name

  • 45th Annual Meeting of the American-Society-of-Hematology

Conference Location

  • SAN DIEGO, CALIFORNIA

Conference Start Date

  • December 6, 2003

Conference End Date

  • December 9, 2003